Titlebook: Biologic and Systemic Agents in Dermatology; Paul S. Yamauchi Book 2018 Springer International Publishing AG 2018 systemic dermatology.bio

Encomium

書目名稱Biologic and Systemic Agents in Dermatology影響因子(影響力)




書目名稱Biologic and Systemic Agents in Dermatology影響因子(影響力)學(xué)科排名




書目名稱Biologic and Systemic Agents in Dermatology網(wǎng)絡(luò)公開度




書目名稱Biologic and Systemic Agents in Dermatology網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Biologic and Systemic Agents in Dermatology被引頻次




書目名稱Biologic and Systemic Agents in Dermatology被引頻次學(xué)科排名




書目名稱Biologic and Systemic Agents in Dermatology年度引用




書目名稱Biologic and Systemic Agents in Dermatology年度引用學(xué)科排名




書目名稱Biologic and Systemic Agents in Dermatology讀者反饋




書目名稱Biologic and Systemic Agents in Dermatology讀者反饋學(xué)科排名

要素

978-3-319-88337-3Springer International Publishing AG 2018

Spangle

Paul S. YamauchiWritten by leading experts in the field for dermatologists and dermatology residents.Describes the mechanism of action of various systemic and biologic agents, as well as their clinical efficacy and s

步履蹣跚

crescendo

群居動(dòng)物

Kinderarmut und soziale Ausgrenzung in Polen effect of therapy, valid outcome measures are commonly employed in clinical trials and in clinical practice. The most commonly used in psoriasis clinical trials include the Psoriasis Area and Severity Index (PASI), the extent of body surface area involvement (BSA), and various physician or investig

致敬

遣返回國(guó)

needle

https://doi.org/10.1007/978-3-322-92447-6ical functioning. The impact of these diseases on quality of life (QOL) can be significant, and the psychosocial impact of many dermatologic diseases is often more impactful than the physical appearance or symptoms alone. We now know that many chronic dermatologic conditions are more than skin deep,

tenuous

Kinderarmut und soziale Ausgrenzung in Polenn reported and the warning labels have expanded. A variety of issues are now linked to biologic associated tumor necrosis factor-alpha (TNF-α) blocker use. Litigation has occurred with the use of a variety of biologics. The published risks of these agents include the development of lupus and autoimm